Molecular Diversity
125.46, 124.41, 123.31, 122.33, 118.72, 110.16, 62.65,
51.10, 42.52, 14.01, 13.02 ppm, MS (m/z) calc.: 326.36,
found LC–MS: 327.40 [M+1].
General procedure for acid amine coupling reaction
(iii)
1-((1-(2-(4-methylpiperidin-1-yl)-2-oxoethyl)-1H-1,2,3-
triazol-4-yl)methyl)-1H-indole-3-carbaldehyde (6p). of
white solid; m.p. 226–228 °C; 1H NMR (400 MHz, CDCl3):
δ 9.979 (s, H, –CHO), 7.322–8.322 (m, 6H, Ar–H),5.523
(s, 2H, –CH2), 5.192 (s, 2H, –CH2), 3.381–3.411 (dd, 2H,
–CH2, J=2.4 Hz), 2.755–2.822 (td, 2H, –CH2, J=2.4 Hz),
1.581–1.613 (dd, 2H, –CH2, J = 2.4 Hz), 1.361–1.429
(td, 2H, –CH2, J = 2.4 Hz), 1.015–1.087 (m, H, –CH),
0.866–0.906 (d, 3H, –CH3) ppm; 13C NMR (100 MHz,
CDCl3): δ 184.72, 162.51, 142.47, 138.50, 137.00, 125.44,
124.49, 124.33, 123.21, 122.32, 118.68, 110.16, 51.16,
45.59, 42.42, 34.31, 30.81, 21.53 ppm; MS (m/z) calc.:
366.43, found LC–MS: 367.50 [M+1].
In a 50-mL round-bottom fask, corresponding 2-(4-((3-for-
myl-2-substituted-1H-indol-1-yl)methyl)-1H-1,2,3-triazol-
1-yl)acetic acid, amine (p–t), HATU (3 eq) in DMF contain-
ing diisopropyl ethyl amine (3 eq) were mixed thoroughly
and subjected ultrasonication at 28 kHz and 70 W for
30 min. After the completion of the reaction (evidenced by
TLC, ethyl acetate: hexane (8: 2)). Then, 0.1 N HCl solution
was added to it slowly with vigorous stirring. The solid mass
that separated upon cooling was fltered, washed well with
saturated sodium bicarbonate solution followed by water,
dried, afording pure solid compounds.
Characterizations details of all newly synthesized
derivatives
1-((1-(2-(4-methylpiperazin-1-yl)-2-oxoethyl)-1H-1,2,3-
triazol-4-yl)methyl)-1H-indole-3-carbaldehyde (6q). pale
yellow solid; m.p. 211–212 °C; 1H NMR (400 MHz, CDCl3):
δ 9.934 (s, H, –CHO), 7.263–8.302 (m, 6H, Ar–H), 5.633
(s, 2H, –CH2), 5.232 (s, 2H, –CH2), 3.566 (s, 2H, –CH2),
3.391 (s, 2H, –CH2), 2.326–2.377 (m, 4H, –CH2), 2.251 (s,
3H, –CH3) ppm; 13C NMR (100 MHz, CDCl3): δ 184.68,
164.17, 142.07, 140.65, 136.78, 125.37, 124.66, 123.54,
122.55, 120.97, 117.33, 111.33, 53.65, 50.59, 44.57, 41.79,
41.48 ppm; MS (m/z) calc.: 365.44, found: 366.50 [M+1].
1-((1-(2-morpholino-2-oxoethyl)-1H-1,2,3-triazol-4-yl)
methyl)-1H-indole-3-carbaldehyde (6r). pale yellow solid;
2-(4-((3-formyl-1H-indol-1-yl)methyl)-1H-1,2,3-triazol-
1
1-yl)acetic acid (4a). white solid; m.p. 208–209 °C; H
NMR (400 MHz, DMSO-d6): δ 13.294 (s, H, –COOH),
9.945 (s, H, –CHO), 7.258–8.292 (m, 6H, Ar–H), 5.536 (s,
2H, –CH2), 5.114 (s, 2H, –CH2) ppm; 13C NMR (100 MHz,
DMSO-d6): δ 184.41, 177.70, 142.55, 140.36, 138.50,
137.04, 125.43, 124.41, 123.32, 122.28, 118.71, 110.18,
51.47, 42.54, 13.05 ppm. MS (m/z) calc.: 284.28, found
LC–MS: 285.30 [M+1].
2 - ( 4 - ( ( 3 - fo r my l - 2 - m e t hy l - 1 H - i n d o l - 1 - y l )
methyl)-1H-1,2,3-triazol-1-yl)acetic acid (4b). white solid;
m.p. 220–221 °C; 1H NMR (400 MHz, DMSO-d6): δ 13.282
(s, H, –COOH), 9.947 (s, H, –CHO), 7.260–8.296 (m, 6H,
Ar–H), 5.523 (s, 2H, –CH2), 5.108 (s, 2H, –CH2), 2.563 (t,
3H, –CH3) ppm; 13C NMR (100 MHz, DMSO-d6): δ 184.43,
177.78, 142.52, 140.37, 138.54, 137.06, 125.41, 124.45,
123.30, 122.26, 118.73, 110.12, 62.12, 51.10, 42.51 ppm;
MS (m/z) calc.: 298.30, found LC–MS: 299.30 [M+1].
4-ethyl 2-(4-((3-formyl-1H-indol-1-yl)methyl)-1H-1,2,3-
triazol-1-yl)acetate (5a). white solid; m.p. 231–232 °C;
1H NMR (400 MHz, DMSO-d6): δ 9.942 (s, H, –CHO),
7.260–8.294 (m, 6H, Ar–H), 5.523 (s, 2H, –CH2), 5.108
(s, 2H, –CH2), 4.206–4.259 (qt, 2H, –CH2, J = 6.8 Hz),
1.245–1.281 (t, 3H, –CH2, J = 7.2 Hz) ppm; 13C NMR
(100 MHz, DMSO-d6): δ 184.70, 168.40, 142.23, 140.573
136.80, 125.10, 124.70, 123.55, 122.56, 121.00, 117.39,
111.34, 62.13, 50.53, 41.46, 14.63 ppm, MS (m/z) calc.:
312.33, found LC–MS: 313.30[M+1].
1
m.p. 215–216 °C; H NMR (400 MHz, CDCl3): δ 9.987
(s, H, –CHO), 7.298–8.321 (m, 6H, Ar–H), 5.616 (s, 2H,
–CH2), 5.137 (s, 2H, –CH2), 3.527–3.665 (m, 8H, –CH2)
ppm; 13C NMR (100 MHz, CDCl3): δ 184.72, 164.19,
142.02, 140.62, 136.78, 125.40, 124.67, 123.56, 122.56,
120.99, 117.37, 111.33, 66.35, 53.68, 50.60, 42.48 ppm; MS
(m/z) calc.: 353.38, found LC–MS: 354.50 [M+1].
2 - ( 4 - ( ( 3 - fo r my l - 2 - m e t hy l - 1 H - i n d o l - 1 - y l )
methyl)-1H-1,2,3-triazol-1-yl)acetic acid (4b). white solid;
m.p. 220–221 °C; 1H NMR (400 MHz, DMSO-d6): δ 13.282
(s, H, –COOH), 9.947 (s, H, –CHO), 7.260–8.296 (m, 6H,
Ar–H), 5.523 (s, 2H, –CH2), 5.108 (s, 2H, –CH2), 2.563 (t,
3H, –CH3) ppm; 13C NMR (100 MHz, DMSO-d6): δ 184.43,
177.78, 142.52, 140.37, 138.54, 137.06, 125.41, 124.45,
123.30, 122.26, 118.73, 110.12, 62.12, 51.10, 42.51 ppm;
MS (m/z) calc.: 298.30, found LC–MS: 299.30 [M+1].
1-((1-(2-oxo-2-(1H-1,2,4-triazol-1-yl)ethyl)-1H-1,2,3-
triazol-4-yl)methyl)-1H-indole-3-carbaldehyde (6t). off
white solid; m.p. 233–234 °C; 1H NMR (400 MHz, CDCl3):
δ 9.987 (s, H, –CHO), 7.323–8.409 (m, 8H, Ar–H), 5.520 (s,
2H, –CH2), 5.190 (s, 2H, –CH2) ppm; 13C NMR (100 MHz,
CDCl3): δ 185.52, 162.53, 143.55, 142.43, 138.51, 137.00,
125.42, 124.50,124.32, 123.23, 122.34, 118.70, 110.14,
51.44, 42.34 ppm; MS (m/z) calc.: 335.33, found LC–MS:
336.50 [M+1].
Ethyl 2-(4-((3-formyl-2-methyl-1H-indol-1-yl)
methyl)-1H-1,2,3-triazol-1-yl)acetate (5b). white solid; m.p.
238–239 °C; 1H NMR (400 MHz, DMSO-d6): δ 9.947 (s, H,
–CHO), 7.258–7.856 (m, 5H, Ar–H), 5.523 (s, 2H, –CH2),
5.110 (s, 2H, –CH2), 5.522 (s, 3H, –CH3) 1.244–1.282 (t,
3H, –CH2, J=7.2 Hz) ppm; 13C NMR (100 MHz, DMSO-
d6): δ 184.64, 168.90, 142.52, 140.31, 138.50, 137.02,
1 3